Skip to main content

Table 4 Identity and viability of FPMSC post thaw under GMP requirements

From: Optimizing mesenchymal stem cell therapy: from isolation to GMP-compliant expansion for clinical application

Sample ID

W455623000021

W455623000032

W455623000038

W455623000040

Average

CD73+ (%, > 95%)

99.8

99.9

99.8

99.9

99.85 ± 0.06

CD90+ (%, > 95%)

99.8

99.9

99.7

99.9

99.82 ± 0.095

CD105+ (%, > 95%)

99.8

99.7

99.5

99.9

99.72 ± 0.171

HLA-DR < 5%

2.97

1.33

0.12

0.89

1.33 ± 1.20

Viability post thaw

97.1

94.4

93.6

99.8

96.22 ± 2.81